A German medical device and services company agreed to settle charges of violating the anti-bribery, books and records, and internal accounting controls provisions of the Foreign Corrupt Practices Act.
The SEC settled charges against a medical device manufacturer and its wholly owned subsidiary for engaging in "hundreds of sham transactions with distributors" in violation of the Foreign Corrupt Practices Act.
FinCEN issued an advisory regarding changes to the lists of jurisdictions with strategic Anti-Money Laundering and Counter-Terrorist Financing ("AML/CFT") deficiencies. The lists were compiled by the Financial Action Task Force ("FATF"). The changes affect the due diligence obligations of U.S...
Request delivery of the Cadwalader Cabinet Newsletter.